BuzzSparks.org

Cara Therapeutics


Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical development opportunities combined with proprietary...

Homepage:
Total money raised: $38.7M

06484 One Parrott Drive

Shelton
USA CT

Phone: 203-567-1500

Updated on Oct 31, 2010
Cara Therapeutics at CrunchBase
Kevin Crowley Board of Directors
Past

July, 2010

Cara Therapeutics raised $15M in a Series D round from Rho Capital Partners, Alta Partners, Connecticut Innovations, MVM Life Science Partners, Mitsubishi Corporation, Scottish Widows Investment Partnership, Ascent Biomedical Ventures, and Devon Park BioVentures

Cara rounds up $15M for post-op pain drug Read more: Cara rounds up $15M for post-op pain drug    fiercebiotech.com

November, 2006

Cara Therapeutics raised $19M in a Series C round from MVM Life Science Partners, Alta Partners, and Ascent Biomedical Ventures

Cara Therapeutics Secures $19 Million in Series C Financing.    thefreelibrary.com

December, 2005

Cara Therapeutics raised $4.7M in a Series B round from Ascent Biomedical Ventures and Esperante Ventures